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demonstrate cartilage destructive properties as expressed by an
increased release and a decreased synthesis rate and content
of cartilage proteoglycans. The synovial tissue destructive prop-
erties increase with time after the experimental haemorrhage
(+168%/+260%; -76%/-83%; -18%/-32% respectively, for 24/48
hours).
Conclusions: Although intra-articular blood is cleared within 2
days from the canine knee joint (<10% left), adverse effects
on cartilage and synovium are already initiated within 1 day, and
they are more severe 2 days after the experimental haemorrhage.
Although these are only short-term effects in the canine joint, it
is clear that only a small amount of blood in a joint for a short
period of time can result in a condition signiﬁcantly compromising
the joint.
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OXIDIZED LDL ENHANCES MCP-1 EXPRESSION IN
CULTURED HUMAN CHONDROCYTES THROUGH
ACTIVATION OF NF-kappaB
A. Ueda, M. Akagi, K. Nakatani, S. Kanata, S. Asada,
C. Hamanishi
Kinki University School of Medicine, Osaka-Sayama City, Japan
Purpose: Recently, it has been demonstrated that lectin-like
ox-LDL receptor-1 (LOX-1) is expressed on chondrocytes and
suggested in vitro and vivo that its ligand ox-LDL play some
role in degeneration of articular cartilage. To investigate whether
oxidized low-density lipoprotein (ox-LDL) binding to lectin-like
ox-LDL receptor 1 (LOX-1) enhances monocyte chemoattrac-
tant protein 1 (MCP-1) expression in cultured human articular
chondrocytes (HACs). Furthermore, to ascertain whether the
ox-LDL-induced MCP-1 upregulation is mediated by NF-kappaB
activation.
Methods: The time course and dose response of MCP-1 mRNA
expression and MCP-1 protein release into medium following
ox-LDL stimulation were investigated using RT-PCR and ELISA,
respectively. HACs were also preincubated with anti-human LOX-
1 mAb (TS92) and speciﬁc NF-kappaB inhibitors (BAY11-7082,
MG132, and SN50). Whole cell extracts from HACs treated
for the indicated periods with ox-LDL and preincubated with
the TS92 were prepared, and NF-kappaB activation (p65 DNA
binding activity) following ox-LDL stimulation was investigated by
ELISA.
Results: LOX-1 mRNA expression in HACs was conﬁrmed by
RT-PCR. Ox-LDL signiﬁcantly increased MCP-1 mRNA and pro-
tein expression levels in a time- and dose-dependent manner,
which was suppressed markedly by pretreatment with TS92
and NF-kappaB inhibitors (Fig. 1). Ox-LDL stimulation activated
NF-kappaB in HACs in a dose-dependent manner, which was
suppressed by TS92 pretreatment (Fig. 2). NF-kappaB inhibitors
signiﬁcantly suppressed ox-LDL-induced MCP-1 expression.
Conclusions: It has been reported that chemokines produced by
chondrocytes and chemokine receptors expressed on chondro-
cytes play an important role in pathogenesis of arthritis through
intra-articular recruitment of monocytes/macrophages and the
activation of matrix degrading enzymes. Our results suggest that
the ox-LDL binding to LOX-1 enhances MCP-1 expression in
human articular chondrocytes through activation of NF-kappaB
and supports the hypothesis that ox-LDL deposition in cartilage
and its receptor LOX-1 expression on chondrocytes are involved
in degeneration of cartilage in osteoarthritis and rheumatoid
arthritis.
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CATABOLIC PROGRAM OF HUMAN OSTEOARTHRITIC
CHONDROCYTES BUT NOT ON SYNOVIAL FIBROBLAST
IN CULTURE
M. Alvarez-Soria, R. Largo, J. Moreno-Rubio,
O. Sánchez-Pernaute, G. Herrero-Beaumont
Fundacion Jimenez Diaz, Madrid, Spain
Purpose: It has been proposed that diacerhein acts as a slow-
acting, symptom-modifying and perhaps as a disease-structure
modifying drug in the treatment of osteoarthritis (OA), although its
effects on cartilage and synovial catabolic program remain poorly
studied. This work was designed to simultaneously study the
effects of diacerhein and that of conventional symptomatic drugs,
like NSAIDs, on the synthesis of inﬂammation and structural
mediators in OA chondrocytes and synoviocytes in culture.
Methods: Chondrocytes and synoviocytes were obtained from
joint specimens of OA patients who underwent total knee re-
placement surgery. We used quiescent cells stimulated with
10 U/ML IL-1β, and studied the effects of diacerhein (10-5M),
celecoxib (CBX, 10-6M), diclofenac (DCF, 10-6M), meloxicam
(MXC, 10-6M) and indomethacin (IND, 10-6M) in the release of
prostaglandin (PG) E2 and nitric oxide (NO), the expression of
cyclooxigenase (COX)-2, the accumulation of metalloproteinase
(MMP)-1 and MMP-13, and the activation of the nuclear fac-
tor kappa B (NF-kB). All drugs were tested at the mean peak
plasma concentration (Cmax) observed after oral administration
of a therapeutic dose.
Results: The activation of NF-kB binding induced by IL-1 was
inhibited by diacerhein, both in chondrocytes and synoviocytes.
All of the NSAIDs used in these experiments also inhibited the
activation of NF-kB induced by IL-1, although IND only showed
this effect on chondrocytes. Regarding the prostaglandin system,
we showed that diacerhein did not revert the increase in COX-2
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synthesis and in PGE2 release elicited by IL-1 in chondrocytes.
Furthermore, in synoviocytes, diacerhein not only did not inhibit
the release of these mediators but even super-induced their
expression and synthesis. NSAIDs diminished until almost basal
levels the PGE2 release, and, unexpectedly, these drugs also
diminished COX-2 synthesis in both cell types. In relation to the
increase in NO synthesis evoked by IL-1 in chondrocytes, only
diacerhein was able to prevent it, while no effect was noted
for the NSAIDs. Diacerhein did not modify the synthesis of
MMPs induced by IL-1 in chondrocytes, but it decreased MMP-
13 accumulation in synoviocytes. In contrast, NSAIDs induced
in both cell types a further increase in MMP1 in IL-1 treated
cells, as well as an enhancement of MMP-13 accumulation in
chondrocytes.
Conclusions: Diacerhein inhibited the activation of NF-kB in-
duced by IL-1 in both cell types and the synthesis of NO in OA
chondrocytes, whereas it failed in the control of PGE2, COX-2
and MMPs in any of the cell types. Taken together these results
would anticipate a weak clinical response to diacerhein in OA. In
turn, the NSAIDs inhibited NF-kB activation and PGE2 release
in these cells, but they were unable to control MMP activation,
in accordance with their presumed “symptom relieving” but not
“disease modifying” role in the treatment of OA.
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RESPONSE OF CARTILAGE AND SYNOVIAL TISSUE
EXPLANTS TO IL-1β IN VITRO
A.M. Stoker, J.L. Cook, J. Luther
University of Missouri Columbia, Columbia, MO
Purpose: The cytokine IL-1β has been shown to play an im-
portant role in the development and progression of osteoarthritis
clinically. The objectives of this study were 1) To determine the
response of cartilage and synovial tissues to IL-1β treatment in
mono-culture compared to untreated controls and each other, 2)
To determine the effect of cartilage and synovial tissue co-culture
on the response to IL-1β treatment on speciﬁc biomarkers com-
pared to untreated controls and mono-culture tissue, 3) Identify
potential biomarkers for the screening of potential treatments of
OA using the in vitro co-culture model.
Methods: Full thickness articular cartilage (CART) and synovial
(SYN) tissue was harvested from cats (n=4) euthanatized for
reasons unrelated to this study, and 3mm CART and SYN tissue
explants were created for culture. CART and SYN tissues were
cultured alone as a mono-culture or together as a co-culture in
media supplemented with ITS serum replacement and with or
without rhIL-1β (100ng/ml). Tissues (N=12) were cultured for 3 or
15 days. Media was changed every 3 days and collected at the
time media change and tissue harvest for biomarker analysis.
Media was tested for NO, PGE2, GAG, and MMP 1, 2, 3, 9, and
13. Tissues harvested on days 3 and 15 were analyzed for GAG
and HP content. Data was analyzed for signiﬁcance by One-Way
ANOVA with signiﬁcance set at p<0.05.
Results: Media PGE2 and No: IL-1β treated CO samples re-
leased signiﬁcantly more PGE2 compared to untreated controls
in the CO and SYN MONO tissues. There was not a signiﬁcant
difference in the release of PGE2 to the media by CART MONO
tissues treated with or without IL-1β. IL-1β treated CO and CART
MONO samples released signiﬁcantly more NO compared to
untreated controls. There was not a signiﬁcant difference in the
release of NO to the media by SYN MONO tissues treated with
or without IL-1β.
Tissue GAG and HP: There was a signiﬁcant decrease in the
GAG content of the CART tissue in IL-1β treated CO and MONO
samples compared to untreated controls at day 15. The HP con-
tent of the CO CART explants treated with IL-1β was signiﬁcantly
lower than untreated controls on day 15.
Media GAG: There was signiﬁcantly more GAG released to
the media of CO and CART MONO tissues treated with IL-1β
compared to untreated controls through day 9 of culture.
Media MMP: There was not a signiﬁcant difference between IL-
1β treated samples and control samples for MMP-1 and MMP-2.
MMP-3, MMP-9, and MMP-13 concentrations were signiﬁcantly
higher in IL-1β treated samples compared to untreated controls.
MMP-2 was signiﬁcantly higher in the SYN MONO compared to
the CART MONO samples. MMP-13 was signiﬁcantly higher in
the CART MONO compared to the SYN MONO samples.
Conclusions: The present study indicates that the co-culture
model results in a signiﬁcant cartilage GAG loss, increased
inﬂammation, and increased release of degradative enzymes.
The data indicates that the CART explant is primarily responsible
for the release of NO and the SYN is primarily responsible for the
release of PGE2. As we continue to characterize the co-culture
model, more potential testing strategies and biomarkers have
been identiﬁed that can be used to evaluate the effectiveness
of potential treatments of osteoarthritis. Further, by identifying
the source of speciﬁc biomarkers, a better understanding of the
role each tissue plays in the pathobiology of OA is gained. By
understanding how each tissue reacts to speciﬁc stimuli, and
how the response of each tissue affects the other, it is possible
that treatments can be designed to target either the cartilage or
synovial tissue to block speciﬁc responses within each tissue for
the treatment of OA.
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STRONTIUM CHLORIDE EXERTS DEGENERATIVE
CHANGES ON JOINT CARTILAGE IN OVARIECTOMIZED
AND SUBJECTED TO RUNNING RATS
J.E. Badurski1, L. Zimnoch2, J. Supronik3, K. Naruszewicz3
1Osteoporosis & Osteo-Articular Diseases Centre, Bialystok,
Poland; 2Anatomy Dept. Medical University, Bialystok, Poland;
3Internal Dis.& Rheumatology Dept. Sniadecki Hospital,
Bialystok, Poland
Purpose: Strontium Ranelate (SR) is widely used as an anti-
osteoporotic agent due to its proven double mode of action, in-
hibition of bone resorption and stimulation of bone formation. In
chondrocytes culture showed stimulatory effect on cartilage ma-
trix compound secretion into media, and also showed inhibitory
effect on excretion of cartilage markers in postmenopausal
women. Its anti-arthritic action is expected. In previous works
in rats we described comparable concentration of Strontium
Chloride (SCh) after i.v. administration in joint cartilage and in
bone tissue as well as deleterious on knee joint cartilage effect
of intensive running training in ovariectomized female rats.
Methods: In this experiment we examine histomorphological fea-
tures of eight group (ca 12 rats per group) of the female rats knee
joint cartilages (FRKJC) after three months of running exercise
(RE) 2 hr per day six days per week with (OVX) and without
(Intact rats - IR) ovariectomy treated or not with one p.o. given
dosage of SCh comparing them to placebo (PL) treated and
shame operated (ShO) group of rats. For evaluation of cartilage
morphology we used Ostergaard histologic/histochemical grad-
ing system assessing structure, cells, safranin stain, tidemark
integrity, and total score indicating the higher score the more
advance degenerative changes.
Results: Results are as follow: Group of IR+PL = (score) 1.85;
RE = 2.00; ShO = 2.00; RE+OVX = 2.00; OVX only = 3.50;
SCh only = 3.75; RE+OVX+SCh = 4.50; RE+SCh = 5.68 and
OVX+SCh = 5.80. It seems that RE + OVX is less traumatic for
FRKJC then OVX itself and consequently that SCh increased its
deleterious effect on FRKJC of RE + SCh alone and on OVX +
SCh alone than on RE + OVX + SCh.
Conclusions: Strontium Chloride can exert highly degenerative
